Urolithiasis Completed Phase 4 Trials for Ergocalciferol (DB00153)

Also known as: Urolithiases / Urolithiasis (N20-N23) / Urolith

IndicationStatusPhase
DBCOND0032691 (Urolithiasis)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01295879Vitamin D Repletion in Stone Formers With HypercalciuriaTreatment